Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for iSpecimen Inc. (ISPC : NSDQ)

• Company Description    iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $1.08 Daily Weekly Monthly 20 Day Moving Average: 1,148,213 shares Shares Outstanding: 2.52 (millions) Market Capitalization: $2.72 (millions) Beta: 1.65 52 Week High: $50.00 52 Week Low: $1.04 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -29.87% -29.91% 12 Week -56.80% -57.62% Year To Date -89.62% -90.80%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 CABOT ROAD SUITE 1800 - WOBURN,MA 01801 USA ph: 781-301-6700 fax: - info@ispecimen.com http://www.ispecimen.com

• General Corporate Information    Officers Katharyn Field - Chief Executive Officer; President; Treasurer and Yuying Liang - Chief Financial Officer Avtar Dhaliwal - Director Anthony Lau - Director Arphing Lee - Director Peer Information iSpecimen Inc. (CHCR) iSpecimen Inc. (ESRX) iSpecimen Inc. (MYDP) iSpecimen Inc. (COR) iSpecimen Inc. (GBCS) iSpecimen Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 45032V306 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/16/26 Share - Related Items Shares Outstanding: 2.52 Most Recent Split Date: 4.00 (0.03:1) Beta: 1.65 Market Capitalization: $2.72 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/16/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.95 Price/Cash Flow: - Price / Sales: 5.82 EPS Growth vs. Year Ago Period: 94.17% vs. Previous Quarter: 85.29% Sales Growth vs. Year Ago Period: -78.68% vs. Previous Quarter: -2.56% ROE 09/30/26 - - 06/30/26 - -524.39 03/31/26 - -584.65 ROA 09/30/26 - - 06/30/26 - -140.42 03/31/26 - -142.48 Current Ratio 09/30/26 - - 06/30/26 - 0.82 03/31/26 - 0.62 Quick Ratio 09/30/26 - - 06/30/26 - 0.82 03/31/26 - 0.62 Operating Margin 09/30/26 - - 06/30/26 - -2,445.40 03/31/26 - -1,080.16 Net Margin 09/30/26 - - 06/30/26 - -2,445.40 03/31/26 - -1,080.16 Pre-Tax Margin 09/30/26 - - 06/30/26 - -2,445.61 03/31/26 - -1,080.25 Book Value 09/30/26 - - 06/30/26 - 1.14 03/31/26 - 1.10 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©